The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s oncology based in vivo CRO market report forecasts the oncology based in vivo CRO market size to grow to $1.79 billion by 2027, with a CAGR (compound annual growth rate) of almost 9%.

Learn More On The Oncology Based In Vivo CRO Market Report 2023 – https://www.thebusinessresearchcompany.com/report/oncology-based-in-vivo-CRO-global-market-report

Oncology Based In Vivo CRO Market Size Forecast
The global oncology-based in-vivo CRO market size is expected to grow from $1.18 billion in 2022 to $1.27 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global oncology-based in-vivo CRO market size is expected to reach $1.79 billion in 2027 at a CAGR of 8.9%.

North America held the largest oncology based in vivo CRO market share and was the fastest-growing region in 2022.

Key Oncology Based In Vivo CRO Market Driver ­– Growth In Prevalence Of Cancer
For instance, in 2021, according to the journal published by the American Chemical Society (ACS), a US-based non-profit organization that supports scientific inquiry in the field of chemistry, the global burden of cancer is expected to be 28.4 million cases in 2040, a 47% rise from 2020. The growing prevalence of cancer is driving the oncology-based in-vivo CRO market.

Request for A Sample Of The Global Oncology Based In Vivo CRO Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10521&type=smp

Key Oncology Based In Vivo CRO Market Trend – Product Innovations
Product innovations are a key trend gaining popularity in the oncology-based in-vivo CRO market. Major companies operating in the oncology-based in vivo CRO market are focused on developing new solutions to sustain their position in the market.

Oncology Based In Vivo CRO Market Segment
1) By Indication: Blood Cancer, Solid Tumors, Other Indications
2) By Model: Syngeneic Model, Xenograft, Patient Derived Xenograft (PDX), Other Models
3) By Application: Hospitals, Rehabilitation Centers

Oncology Based In Vivo CRO Market Major Players and Strategies
Major players in the oncology based in-vivo CRO market are Crown Bioscience, Charles River Laboratory International, Toxicon Inc., The Jackson Laboratory, ICON Plc., Wuxi AppTec., Eurofins Scientific Group, Taconic Biosciences Inc., Labcorp Drug Development, Champion Oncology Inc., Xentech Inc., Thermo Fisher Scientific Inc., MI Bioresearch Inc., Clintec International Private Limited, Worldwide Clinical Trials, Pharm-Olam LLC and Clinipace Clinical Research Private Limited.

In March 2023, ClinChoice Medical Development, a US-based contract research organization (CRO) that provides research services to accelerate drug and device approvals, acquired Cromsource S.r.l. for an undisclosed amount. Through this acquisition, ClinChoice Medical Development expands its operational capabilities with additional delivery hubs to complement its existing network in Europe and the US. Data science technology offerings in several areas, including risk-based monitoring and decentralized clinical trials, are expanded through acquisition. Cromsource S.r.l. is an Italy-based contract research organization that provides full-research services to the pharmaceutical, biotechnology, and medical device industries.

The Oncology Based In Vivo CRO Global Market Report 2023 covers regional data on oncology based in vivo CRO market size, oncology based in vivo CRO market trends and drivers, opportunities, strategies, and oncology based in vivo CRO market competitor analysis. The countries covered in the oncology based in vivo CRO market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

An oncology-based in-vivo contract research organization (CRO) refers to a company hired by another company to perform complete or partial steps of running a preclinical in-vivo study (testing or with living organisms such as animals, plants, or whole cells), such as designing, managing, monitoring, and analyzing in-vivo preclinical results for oncology drugs or devices.

View More Reports Related To The Oncology Based In Vivo CRO Market –
Oncology Biosimilars Global Market Report 2023
Oncology Devices Global Market Report 2023
Oncology Molecular Diagnostics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: